Jason Pitofsky
SVP Controller · Regeneron Pharmaceuticals, Inc. (REGN)
sold: $3,827,159 · planned sales: $3,789,808
| Date | Trade | Shares | Avg. price | Value | Filing |
|---|---|---|---|---|---|
| November 4, 2026 | Planned sale | 3,883 | — | $3,789,808 | SEC |
| November 4, 2026 | Sale | 4,062 | $942.19 | $3,827,159 | SEC |
Shown: open-market purchases and sales (Form 4, codes P and S) and notices of planned sales (Form 144), values as filed. Not shown: grants, tax withholding, gifts and option exercises — they are not trades. A disclosed trade does not show how the person rates the company and is not a recommendation.
